Presentation is loading. Please wait.

Presentation is loading. Please wait.

Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus  George L. Bakris, MD  Mayo Clinic.

Similar presentations


Presentation on theme: "Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus  George L. Bakris, MD  Mayo Clinic."— Presentation transcript:

1 Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus  George L. Bakris, MD  Mayo Clinic Proceedings  Volume 86, Issue 5, Pages (May 2011) DOI: /mcp Copyright © 2011 Mayo Foundation for Medical Education and Research Terms and Conditions

2 FIGURE A suggested approach to achieve blood pressure goal in patients with diabetes. An estimated glomerular filtration rate (eGFR) of ≥50 mL/min/1.73 m2 generally responds well to thiazide diuretics. Chlorthalidone is the suggested thiazide-like diuretic because it is the diuretic used in clinical trials and forms the basis for the cardiovascular outcomes data. Vasodilating β-blockers have a better tolerability profile and fewer metabolic consequences compared with older agents such as atenolol. ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; CCB = calcium channel blocker. From J Am Soc Hypertens,54 with permission from Elsevier. Mayo Clinic Proceedings  , DOI: ( /mcp ) Copyright © 2011 Mayo Foundation for Medical Education and Research Terms and Conditions


Download ppt "Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus  George L. Bakris, MD  Mayo Clinic."

Similar presentations


Ads by Google